METABolic Deterioration in HTX Determines Outcomes
Recruiting
Observational Study
Heart Transplantation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 270 (estimated)
- Sponsor
- Heinrich-Heine University, Duesseldorf · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age: ≥ 18 years
* Planned or already conducted heart transplantation
* Informed consent
Exclusion Criteria:
* Absence of informed consent
Contacts